The UK has given around 25% of its population a first dose, but across the world fewer than 3% of people have received a vaccine.
L’expertise universitaire, l’exigence journalistique
Articles sur COVID-19
Affichage de 3301 à 3320 de 7949 articles
A stamp duty holiday announced to avoid a housing market crash is not all it was cracked up to be.
A transcript of The Conversation Weekly podcast episode #3.
While some of the authorised COVID-19 vaccines are grown, others are built.
A survey of the impact of the first few rounds of coronavirus aid shows that most of those who lost jobs or wages due to the pandemic were facing severe economic hardship.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
Children in the study seemed to display a very strong “innate” immune response.
The clock starts ticking once the vaccine leaves the freezer. Here’s what to expect.
The Pfizer vaccine rolls out to high-risk people in Australia from next week. And many of these front-line workers will be women. Here’s what we know so far.
Early into the pandemic there were cries and questions as to whether the cinema industry would survive. The answer, it seems, was here all along. A robust and diverse local industry.
Maintaining antibodies in the blood requires creating certain long-lasting immune cells – but this doesn’t always happen.
COVID-19 has exposed how systemic racism affects the lives of many racialized students in Canada. But what are some possible solutions?
A focus on ‘catching up’ implies a deficit on the part of pupils.
Cities have long resisted the public demand for street food vendors, but the pandemic may reverse those restrictions for good.
‘Long COVID’ – in which people have symptoms lasting more than a few weeks – is turning out to be very common. People hospitalized for COVID-19 are at highest risk, but they aren’t alone.
A spike in cases has been reported among young people in Israel and Italy.
Three years ago, research findings showed that consultants were making UK health service more inefficient. Now a follow-up finds that the problem is getting worse.
The Oxford/AstraZeneca vaccine is the second COVID shot to be approved in Australia, and it’s likely Australians will start receiving it next month.
We need to rigorously analyse data from recent lockdowns, so we can respond better to future outbreaks.
Too much COVID-19 news could be harmful to your health, experts suggest. So how do you stay informed but not get depressed?
Les contributeurs les plus fréquents
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
